Skip Navigation LinksHome/Activities/Connect to Win/2025

Activities

Connect To Win

Connect to Win 2025
Dates: November 24-25, 2025
Location: Brussels, Belgium

Attachments

Monday November 24th, 2025

  • Welcome and Introduction

    Speaker: Prof. Giovanni Tonon

  • SESSION 1: Methods & Methodologies underlying RWE & Clinical Trials

    Session Chair: Prof. Giovanni Tonon

  • Generalization of population causal measures (Risk Difference, Risk Ratio, OR, etc.) from one trial to a target population

    Speaker: Prof. Julie Josse

  • No Magic Wand: Real Value in Oncology RWE Comes from the Broom and the Hammer

    Speaker: Prof. Asieh Golozar

  • The Magic Randomisation versus the Myth of Real World Evidence

    Speaker: Prof. Richard Bulbulia

  • Data-Driven Decisions in Prostate Cancer: From Noisy Data to Clinical Insight

    Speaker: Dr. Susan Evans Axelsson

  • SESSION 2: Real-World Evidence: Policy, Practice, and Patient Impact in Precision Medicine

    Session Chair: Prof. Andre Dekker

  • EU Missions, Cancer: Concrete solutions for our greast challenges

    Dr. Jan-Willem van de Loo

  • Proton Therapy in the Netherlands - A Precision Medicine Initiative

    Dr. Prof. Andre Dekker

  • SESSION 3:  Collaborative Research Development

  • DIGICORE Collaborative Research: Working Groups, the past, the present & the future

    Dr. Alberto Traverso

  • DIGICORE Collaborative Research: Sharing best practices

    Dr. Alberto Traverso

Tuesday, November 25th, 2025

  • KEYNOTE: Therapeutic Vaccines in Oncology

    Prof. Christophe Le Tourneau

  • SESSION 4: Real-World Evidence in Practice: Value of RWE in Cancer Research

    Session Chair: Prof. Gennaro Ciliberto

  • DINASTY in NSCLC

    Dr. Asa Ojlert

  • The Omics Breakthrough: Radiotherapy Reinvented

    Dr. Luca Boldrini

  • Radiotherapy - AI - Radiomics: Not a simple entity

    Prof. Dirk de Ruysscher

  • Beyond prospective trials: real-world evidence informing breast cancer practice

    Dr. Cédric Van Marcke

  • AI to improve the management of patients with clonal hematopoiesis

    Prof. Matteo Giovanni Della Porta

  • SPOREDATA WORKSHOP: United in Discovery: The Future of DIGICORE Research Proposals

    Speaker: Dr. Ricardo Pietrobon

  • SESSION 5: Dragon’s Den

  • DIGICORE Scientific Working Group: Breast. Study proposals for Connect To Win

  • DIGICORE Scientific Working Group: Lung. Study Proposals: Oligo-progressive disease outcomes for mNSCLC

  • DIGICORE Scientific Working Group: RWE/Tech. Evaluating AI Assistance in Multicenter Multidisciplinary Oncology Teams

  • SESSION 6: Tools for Real-World Evidence

  • From Cloud to bedside: the pitfalls and the opportunities of AI in medicine

    Dr. Carlo Tacchetti

  • From EMR to Evidence: IQVIA HIS as a Strategic Enabler

    Dr. Ernest Sarrias

  • A Practical Roadmap for Extracting Structured Oncology Data from Free-text records using Open-source NLP Tools

    Dr. Mindaugas Morkunas